Your browser doesn't support javascript.
loading
Feasibility of Fitbit Use in Adolescent Survivors of Pediatric Cancer: Who Consistently Uses It and for How Long?
Williamson Lewis, Rebecca; Howell, Kristen E; Effinger, Karen E; Meacham, Lillian R; Wasilewski-Masker, Karen; Mertens, Ann; Gilleland Marchak, Jordan.
Afiliação
  • Williamson Lewis R; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Howell KE; Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Effinger KE; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Meacham LR; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Wasilewski-Masker K; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Mertens A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Gilleland Marchak J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
J Adolesc Young Adult Oncol ; 12(4): 529-536, 2023 08.
Article em En | MEDLINE | ID: mdl-36178482
ABSTRACT

Purpose:

Wearable activity trackers with real-time feedback and goal-setting features are being incorporated into programs to increase physical activity among childhood cancer survivors. This analysis describes the adoption and use of a Fitbit® Flex™ among adolescent-aged survivors of childhood cancer without incentives, reminders, or interventions to encourage use. Procedures Cancer survivors aged 13-18 and ≥2 years from therapy received a Fitbit Flex with instructions to wear it daily. Researchers downloaded participants' daily total steps and active minutes for 1 year. Participants were classified as consistent (≥5 days/week for >4 weeks during the first 12 weeks) or inconsistent users, and comparisons between user types were made. Longitudinal use of the Fitbit and participants' 1-year acceptability evaluations are described.

Results:

Overall, 67.1% (47/70) of survivors enrolled, and Fitbit data were available for 36 participants. Initially, 30.6% (11/36) were consistent users. Consistent users had lower body mass index z-scores at enrollment (0.4 ± 0.7 vs. 1.2 ± 0.9; p = 0.01), but were otherwise comparable with inconsistent users. Over time survivors' use declined; at 12 months, only one participant was using his or her Fitbit. Survivors who completed a survey (n = 22) reported their Fitbit helped them self-monitor their exercise (72.7%, 16/22) and lead a more active lifestyle (63.6%, 14/22), but found it challenging to charge and not lose, forget about, or break the device.

Conclusions:

In the real-world setting, only a small subset of adolescent-aged survivors will initially consistently use a Fitbit and their interest diminishes over time. To maximize engagement, interventions incorporating wearable activity trackers likely need to include additional behavior change strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monitores de Aptidão Física / Neoplasias Limite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Adolesc Young Adult Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monitores de Aptidão Física / Neoplasias Limite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Adolesc Young Adult Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos